Drugs Made In America Acquisition II Corp. Announces $1.4 Million Convertible Notes Financing Agreement with Alpha Multi Family Office

NodeGuardian · 2026-04-07T16:23:10+00:00

Drugs Made In America Acquisition II Corp. has obtained a $1.4 million financing agreement from S.E.E Capitals Ltd. for operational costs, with potential equity dilution for the investor. The company is also facing a sponsor transition due to issues with the current sponsor.

NodeGuardian

2026-04-07 16:23:10

Abstract generation in progress

Drugs Made In America Acquisition II Corp. has secured a $1.4 million convertible notes financing agreement from S.E.E Capitals Ltd., with the funds allocated for operational and regulatory costs. The agreement includes provisions for potential share dilution if the investor converts notes into equity at a 35% discount following a business combination. Additionally, the company is undergoing a sponsor transition due to the current sponsor’s non-performance and legal issues.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.